Page last updated: 2024-08-22

ruthenium and sulfamethoxypyridazine

ruthenium has been researched along with sulfamethoxypyridazine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Castilho, N; de Melo, ACC; de Oliveira, GAP; de Souza, ÍP; Gabriel, P; Marques, MA; Moraes, AH; Nunes, KJRC; Pereira-Maia, EC; Rodrigues, BL; Santana, JMSVP; Terenzi, H	1

Other Studies

1 other study(ies) available for ruthenium and sulfamethoxypyridazine

Article	Year
New Heteroleptic Ruthenium(II) Complexes with Sulfamethoxypyridazine and Diimines as Potential Antitumor Agents. Molecules (Basel, Switzerland), 2019, Jun-07, Volume: 24, Issue:11 Topics: Antineoplastic Agents; Circular Dichroism; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Structure; Organometallic Compounds; Proto-Oncogene Proteins c-abl; Ruthenium; Spectrometry, Mass, Electrospray Ionization; src Homology Domains; Sulfamethoxypyridazine; X-Ray Diffraction	2019

Article

Year

New Heteroleptic Ruthenium(II) Complexes with Sulfamethoxypyridazine and Diimines as Potential Antitumor Agents.

Molecules (Basel, Switzerland), 2019, Jun-07, Volume: 24, Issue:11

Topics: Antineoplastic Agents; Circular Dichroism; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Structure; Organometallic Compounds; Proto-Oncogene Proteins c-abl; Ruthenium; Spectrometry, Mass, Electrospray Ionization; src Homology Domains; Sulfamethoxypyridazine; X-Ray Diffraction

2019